| Hans-Günter Meyer-Thompson | Hepatitiden
Prioritize Injection Drug Users for Hepatitis C Treatment
Paris. To eliminate the hepatitis C virus, funding must be prioritized for the treatment of people at high risk of spreading the infection, even if it is at the expense of people at lower risk for transmission, according to one expert at the International AIDS Society 2017 Conference in Paris.
"This means targeting people who inject drugs," said John Dillon, MD, from the University of Dundee in the United Kingdom.
"Average drug users with HCV are likely to infect two to six people before they move away from drug use," he reported. "A focus on treating people who are HCV-positive and injecting is the only way to slow and prevent spread of the virus." (medscape.com, 27.07.2017)